Clinical Scorecard: Musings from The Power List: Gerrit Renner
At a Glance
| Category | Detail |
|---|---|
| Condition | Analytical data science and trustworthy analytical measurements |
| Key Mechanisms | Data-processing and chemometric approaches that retain uncertainty, quality, and provenance across analytical workflows. |
| Target Population | Researchers and practitioners in analytical science, including those working with complex mass-spectrometric data. |
| Care Setting | Analytical research workflows, from signal recording through processing and scientific interpretation. |
Key Highlights
- Data processing is described as an integral part of analytical measurement, not a separate post-measurement step.
- Processing steps such as centroiding, feature detection, integration, and modeling introduce assumptions and uncertainty.
- The research aims to make processing transparent and quantitative, including propagation of uncertainty and quality measures.
- Machine-actionable analytical data should carry metadata, provenance, uncertainty, and semantic meaning.
- FAIR data practices are advocated throughout the analytical workflow, beginning at acquisition.
Guideline-Based Recommendations
Diagnosis
Management
- Renner describes developing approaches that make processing steps transparent and quantitative, including uncertainty estimates and quality measures that can be propagated through analytical workflows.
- Renner argues that analytical workflows should preserve FAIR, machine-actionable data and its context from acquisition onward.
Monitoring & Follow-up
- Record processing decisions and uncertainty across transformations from detector signal to final result, as advocated by Renner.
- Retain metadata and provenance to support interpretation and reconstruction of analytical results.
Risks
- Renner notes that preprocessing, peak detection, integration, and filtering decisions can substantially affect outcomes.
- Renner warns that context, provenance, and processing information may be lost when FAIR practices are applied only after data generation and processing.
- The source says context may be hidden in proprietary formats, software settings, or scientists’ notebooks, and processing decisions can be difficult to reconstruct.
Patient & Prescribing Data
Not applicable; the article concerns analytical science and data workflows, not patient care.
No treatments or prescribing information are discussed.
Clinical Best Practices
- Renner describes data structures, algorithms, statistics, and scientific interpretation as parts of the same measurement chain.
- Renner argues that FAIR and machine-actionable data should be maintained throughout the workflow, beginning at acquisition.
- Preserve information about how analytical values were produced and their uncertainty and quality, consistent with Renner’s stated research focus.
Related Resources & Content
Based on findings from:
Musings from The Power List: Gerrit Renner
The Analytical Scientist, 2026.
https://theanalyticalscientist.com/issues/2026/articles/october/musings-from-the-power-list-gerrit-renner/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.